Revenue: The sum of all revenue fields included for a company's operating activities.
Lexicon Pharmaceuticals, Inc. (LXRX) had Revenue of $31.08M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
$31.08M |
$-200.40M |
|
$0.62M |
|
$30.46M |
|
$228.20M |
|
$-197.12M |
|
$-3.29M |
|
$-200.40M |
|
$-200.40M |
|
$-200.40M |
|
$-200.40M |
|
$-200.40M |
|
$-200.40M |
|
$-197.12M |
|
$-194.74M |
|
320.03M |
|
320.03M |
|
$-0.63 |
|
$-0.63 |
|
| Balance Sheet Financials | |
$246.19M |
|
$2.48M |
|
$52.23M |
|
$298.42M |
|
$45.25M |
|
$100.30M |
|
$107.22M |
|
$152.47M |
|
$145.95M |
|
$101.41M |
|
$145.95M |
|
361.49M |
|
| Cash Flow Statement Financials | |
$-178.78M |
|
$-15.38M |
|
$238.35M |
|
$22.46M |
|
$66.66M |
|
$44.19M |
|
$13.50M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.44 |
|
-- |
|
-- |
|
0.41 |
|
0.69 |
|
98.02% |
|
-634.20% |
|
-634.20% |
|
-626.55% |
|
-644.78% |
|
-644.78% |
|
$-179.81M |
|
-- |
|
-- |
|
-- |
|
0.10 |
|
2.67 |
|
8.95 |
|
40.79 |
|
-137.31% |
|
-197.62% |
|
-67.15% |
|
-81.38% |
|
$0.40 |
|
$-0.56 |
|
$-0.56 |
|